Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Guo-qing Cao
Acute and Chronic Administration of SHR117887, a Novel and Specific Dipeptidyl Peptidase-4 Inhibitor, Improves Metabolic Control in Diabetic Rodent Models
Acta Pharmacologica Sinica
Medicine
Pharmacology
Related publications
Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
Pharmacokinetic and Pharmacodynamic Interactions Between Metformin and a Novel Dipeptidyl Peptidase-4 Inhibitor, Evogliptin, in Healthy Subjects
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Dipeptidyl Peptidase 4 Inhibitor Improves Brain Insulin Sensitivity, but Fails to Prevent Cognitive Impairment in Orchiectomy Obese Rats
Journal of Endocrinology
Endocrinology
Metabolism
Diabetes
Dipeptidyl Peptidase-4 (DPP-4; CD26)
Science-Business eXchange
Effect of Vildagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Cardiac Hypertrophy Induced by Chronic Beta-Adrenergic Stimulation in Rats
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Chronic Inhibition of Dipeptidyl Peptidase-4 With a Sitagliptin Analog Preserves Pancreatic -Cell Mass and Function in a Rodent Model of Type 2 Diabetes
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Novel Potentials of Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Against Ischemia-Reperfusion (I/R) Injury in Normolipidemic and Hyperlipidemic Animals
Effect of Renal Insufficiency on the Pharmacokinetics of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Suppression of Abdominal Aortic Aneurysm Formation in Mice by Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor
Journal of Atherosclerosis and Thrombosis
Biochemistry
Internal Medicine
Cardiovascular Medicine
Cardiology
